IMM 1.49% 34.0¢ immutep limited

endpoints for immunotherapy, page-10

  1. 1,235 Posts.
    lightbulb Created with Sketch. 97
    The first one approved by FDA was provenge By Dndreon ,a similar PFS at ph2 to cvac and a similar dendritic treatment focussing on muc1 secreting tumours.
    OS proved to be vey good and hence FDA approval but it was a very bumpy ride to approval. Just look at dendreon's chart over the years leading to approval.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.005(1.49%)
Mkt cap ! $493.8M
Open High Low Value Volume
33.5¢ 34.0¢ 33.0¢ $1.220M 3.642M

Buyers (Bids)

No. Vol. Price($)
3 57289 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 52306 3
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.